DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Kennelly M, Dmochowski R, Schulte-Baukloh H. , et al.
Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: final results of a long-term extension study.
Neurourol Urodyn 2017;
36: 368-375
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.